318 related articles for article (PubMed ID: 12786942)
21. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.
Eberhardt W; Huwiler A; Beck KF; Walpen S; Pfeilschifter J
J Immunol; 2000 Nov; 165(10):5788-97. PubMed ID: 11067938
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
Zhang L; Himi T; Morita I; Murota S
Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
[TBL] [Abstract][Full Text] [Related]
23. IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways.
Lee ZH; Lee SE; Kim CW; Lee SH; Kim SW; Kwack K; Walsh K; Kim HH
J Biochem; 2002 Jan; 131(1):161-6. PubMed ID: 11754748
[TBL] [Abstract][Full Text] [Related]
24. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells.
Cho A; Graves J; Reidy MA
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2527-32. PubMed ID: 11116048
[TBL] [Abstract][Full Text] [Related]
25. The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.
Newton R; Cambridge L; Hart LA; Stevens DA; Lindsay MA; Barnes PJ
Br J Pharmacol; 2000 Jul; 130(6):1353-61. PubMed ID: 10903976
[TBL] [Abstract][Full Text] [Related]
26. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PI3K in human airway epithelial cells.
Kim YD; Jeon JY; Woo HJ; Lee JC; Chung JH; Song SY; Yoon SK; Baek SH
J Korean Med Sci; 2002 Dec; 17(6):765-71. PubMed ID: 12482999
[TBL] [Abstract][Full Text] [Related]
28. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase.
Wang X; Mori T; Jung JC; Fini ME; Lo EH
J Neurotrauma; 2002 May; 19(5):615-25. PubMed ID: 12042096
[TBL] [Abstract][Full Text] [Related]
29. Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes.
Zhang QS; Maddock DA; Chen JP; Heo S; Chiu C; Lai D; Souza K; Mehta S; Wan YS
Int J Oncol; 2001 Nov; 19(5):1057-61. PubMed ID: 11605009
[TBL] [Abstract][Full Text] [Related]
30. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
[TBL] [Abstract][Full Text] [Related]
31. Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts.
Barchowsky A; Frleta D; Vincenti MP
Cytokine; 2000 Oct; 12(10):1469-79. PubMed ID: 11023661
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
35. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration.
Tsai HR; Yang LM; Tsai WJ; Chiou WF
Eur J Pharmacol; 2004 Sep; 498(1-3):45-52. PubMed ID: 15363974
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line.
Sautin YY; Crawford JM; Svetlov SI
Am J Physiol Cell Physiol; 2001 Dec; 281(6):C2010-9. PubMed ID: 11698260
[TBL] [Abstract][Full Text] [Related]
37. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells.
Wuyts WA; Vanaudenaerde BM; Dupont LJ; Demedts MG; Verleden GM
Respir Med; 2003 Jul; 97(7):811-7. PubMed ID: 12854631
[TBL] [Abstract][Full Text] [Related]
38. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
Agazie Y; Ischenko I; Hayman M
Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798
[TBL] [Abstract][Full Text] [Related]
39. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.
Wert MM; Palfrey HC
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol-3 kinase-dependent activation of Akt does not correlate with either high mitogenicity or cell migration induced by FGF-1.
Marcinkowska E; Wiedlocha A
Anticancer Res; 2003; 23(5A):4071-7. PubMed ID: 14666721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
